Agencies, 12 May: Covid-19 dawai, Covaxin bona toh Uttar Pradesh’s Bulandshahr te joldi suru koribo. Covaxin toh Hyderabad-based biotechnology company, Bharat Biotech para bona indigenous dawai ase.
Centre para manishe Covaxin toh Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) laga Bulandshar plant te bonabole nemite. Tai khan para hotai moina Covaxin laga 2 crore doses toh bonabole ase.
BIBCOL toh government laga ekta PSU ase. Etu toh 1989 sal Bulandshahar te bonaishe. Etu para oral polio dawai aro tusara immunisers bonai.
Covaxxim manufacturer Bharat Biotech aro BIBCOL para Bulandshahr plant te dawai bonabole MoU sign korise. Ministry of Health para Rs 30 crore financial aid toh Covaxin bonabo nemite debole ase.
BIBCOL para Covaxin toh thaki thaka spare capacity logote bonabo. Production toh joldi suru koribo. Company para poila government directives hisab te Covaxin bonabole paribo koikena janaideya thakise.
Company para thaki thaka facilities logote 6 crore doses polio dawai bonabole pari. Etu opor te, BIBCOL para be Zinc Dispersible Tablets aro Diarrhea Management Kits bonai.
Government para be Covid-19 kelaaf fight te dawai bona te othabo nemite tusara dawai company logote melishe. Poila April te Centre para Haffkine Institute, Mumbai ke Covaxin toh transfer of technology laga basis te bonabo nemite mana thakise.
Aji kali India te Covaxin aro Covishield dawai toh de ase. Pune-bases Serum Institute of India para Covishield (Oxford-AstraZeneca COVID-19 dawai laga local version) toh bonai ase. India te khali tinta dawai – Covaxin, Coveshield aro Sputnik V toh bekhabole manishe. Sputnik V dawai toh Russia para India te anibo nemite Dr Reddy’s para manishe hoilebe etu dawai toh India te sob jaga te napai kena ase.
Add Comment